ANTIHYPERTENSIVE EFICACY OF NOLIPREL A BI-FORTE IN RELATION TO THE PRESENCE OF LEFT VENTRICULAR HYPERTROPHY


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The treatment of arterial hypertension (AH), in patients with target organ lesion in particular, presents considerable difficulties. The full-dose combination of perindopril A (10 mg) indapamide (2,5 mg) (Noliprel A Bi-Forte) is shown to lower blood pressure (BP) in patients with left ventricular hypertrophy to the same degree as in those without target organ lesions and may be effectively used as starting therapy. It is expedient to use 24-hour BP monitoring to control the efficiency of therapy and to decide whether it should be corrected.

全文:

受限制的访问

作者简介

M. Glezer

I.M. Sechenov First Moscow State Medical University; City Clinical Hospital Fifty-Nine

Email: 287ast@mail.ru
Professor MD1,2 Moscow

A. Avakyan

I.M. Sechenov First Moscow State Medical University; City Clinical Hospital Fifty-Nine

Email: 287ast@mail.ru
Moscow

参考

  1. Глезер М.Г., Авакян А.А. Резистентная артериальная гипертония. Пути преодоления проблемы // Проблемы женского здоровья. - 2012; 7 (1): 29-46.
  2. Mourad J., Le Jeune S. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients // Curr. Med. Res. Opin. - 2009; 25 (9): 2271-80.
  3. Маньковский Б.Н., Иванов Д.Д. Влияние антигипертензивной терапии на функцию почек у больных сахарным диабетом 2-го типа: результаты проспективного исследования СКИФ-2 // Лiли Украіни. - 2010; 144 (8): 50-4.
  4. Линчак Р.М. Сопоставление эффективности фиксированной комбинации периндоприла/индапамида при артериальной гипертонии у пациентов разного пола и возраста // Кардиология. - 2010; 50 (6): 35-40.
  5. Pella D. Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme // High Blood Press. Cardiovasc. Prev. - 2011; 18 (3): 107-13.
  6. Глезер М.Г., Авакян А.А.Эффективность и безопасность терапии полнодозовой комбинацией периндоприла А/индапамида (10 /2,5 мг) у пациентов с артериальной гипертонией // Кардиоваск. профилакт. и тер. - 2012; 5: 4-11.
  7. Boggia J., Thijs L., Hansen T. Wetal. International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes Investigators. Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women // Hypertension. - 2011; 57 (3): 397-405.
  8. Wang D., Zhao W., Sun Y. et al. The predictive value of the ambulatory blood pressure monitoring parameters on left ventricular hypertrophy and carotid artery intima-media thickness in hypertensives // Zhonghua Xin Xue Guan Bing Za Zhi. -2005; 33 (3): 243-6.
  9. Cuspidi C., Macca G., Sampieri L. et al. Target organ damage and nondipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients // J. Hypertens. - 2001; 19 (9): 1539-45.
  10. Li Y., Thijs L., Hansen T. et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations // Hypertension. - 2010; 55 (4): 1040-8.
  11. Hansen T., Li Y., Boggia J. et al. Predictive role of the nighttime blood pressure // Hypertension. - 2011; 57 (1): 3-10.
  12. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications // Hypertension. - 2000; 35 (3): 844-51.
  13. Fagard R., Celis H., Thijs L. et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension // Hypertension. - 2008; 51 (1): 55-61.
  14. Stergiou G., Efstathiou S., Skeva I. et al. Comparison of the smoothness index, the trough: peak ratio and the morning: evening ratio in assessing the features of the antihypertensive drug effect // J. Hypertens. - 2003; 21 (5): 913

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2012